Surging cases of the yeast infection is estimated to drive the market’s growth across the globe. According to NCBI studies, in 2018, around 30%-50% of women had vulvovaginal candidiasis at least once in their lives. Moreover, in Asia Pacific, Candida species is the most frequent yeast infection. Consequently, the market is estimated to show substantial growth over the forecasted period.
Global Yeast infection Market was valued at USD 3.88 billion in 2021 and is expected to reach USD 6.23 billion by 2029, registering a CAGR of 6.10% during the forecast period of 2022-2029. The “bacterial” accounts for the largest pathogen segment in the yeast infection market within the forecasted period owing to the rise in the bacterial yeast infection cases and the rising prevalence of HAIs. The market report curated by the Data Bridge Market Research team includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Market Definition
Candidiasis, often known as yeast or fungus infection, is a parasitic ailment. It's a naturally occurring component in the human body. It can cause infection in some cases due to changes in the body's immune level. It can also affect the skin, mouth, and stomach. Yeast infection in the vaginal area is very prevalent among women. Rashes, swelling, redness, stinging, and burning are all symptoms of this infection. Yeast infection can be caused by a lack of immunity, poor cleanliness, or lifestyle disorders.
View Detailed Report@ https://www.databridgemarketresearch.com/reports/global-yeast-infection-market
Drivers
- Growing Prevalence Of Diseases, Infections And Other Ailments
The factors such as the rise in the prevalence of autoimmune disease and yeast infection along with the development of new fungal infections is the most significant factor driving the growth for this market. The rise in the burden of ailments like the cardiovascular, gastrointestinal and other diseases are also expected to accelerate the overall growth of the market.
Furthermore, the improving economic conditions worldwide that enables access to the quality and improved healthcare are also expected to fuel market growth. Moreover, the rising awareness among the patients regarding the yeast infections also cushions the market’s growth within the forecasted period. The rising demand for antifungal drugs and government support for research and development are also projected to bolster the growth of the market.
Opportunities
- Growing Investments and Advancements
Moreover, the financing for the administration of research and development in medical science combined with introduction of new treatment options for yeast infections are estimated to generate lucrative opportunities for the market. The investments in this region for the yeast infection market will further offer numerous growth opportunities for the market.
Some of the major players operating in the yeast infection market are
- Scynexis Inc., (U.S.)
- Merck Co., Inc. (U.S.)
- Bayer AG (Germany)
- Astellas Pharma Inc., (Japan)
- Thermo Fisher Scientific Inc., (U.S.)
- Novartis AG (Switzerland)
- Abbott (U.S.)
- Catalent, Inc., (U.S.)
- bioMérieux (France)
- Pfizer Inc. (U.S.)
- AbbVie Inc., (U.S.)
- ALLERGAN (Ireland)
- Jubilant Pharmova Limited (India)
- Sanofi (France)
- AstraZeneca (U.K)
- Bruker (U.S.)
- Brundavan Laboratories Ltd. (India)
- Curia Global, Inc. (U.S.)
- Corden Pharma (Germany)
https://www.databridgemarketresearch.com/reports/global-dna-vaccines-market
https://www.databridgemarketresearch.com/reports/global-laser-probe-market
https://www.databridgemarketresearch.com/reports/global-brachytherapy-market
https://www.databridgemarketresearch.com/reports/global-cluster-headache-drug-market
https://www.databridgemarketresearch.com/reports/global-coal-workers-pneumoconiosis-drug-market
https://www.databridgemarketresearch.com/reports/global-glaucoma-market
About Data Bridge Market Research:
An absolute way to forecast what the future holds is to comprehend the trend today!
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with an unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.
Contact Us:-
Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Email:- [email protected]
